Trade RCKT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Rocket Pharmaceuticals, Inc. (RCKT) is trading at US$2.56, down 2.66% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$385.31M. Over the past 52 weeks, RCKT has traded between US$2.42 and US$5.45. On Syfe you can trade RCKT with $0 commission and add it to your watchlist.
| Previous close | US$2.63 |
|---|---|
| Market cap | US$385.31M |
| 52-week range | US$2.42 – US$5.45 |
| Volume | 3.37M |
| Exchange | US |
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. The firm's multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Year: 2015
Rocket Pharmaceuticals, Inc. (RCKT) stock is trading at US$2.56, -2.66% from the previous close of US$2.63.
The market cap for Rocket Pharmaceuticals, Inc. (RCKT) stock is approximately US$385.31M.
The 52-week high for Rocket Pharmaceuticals, Inc. (RCKT) stock is US$5.45.
The 52-week low for Rocket Pharmaceuticals, Inc. (RCKT) stock is US$2.42.
Rocket Pharmaceuticals, Inc. (RCKT) does not currently pay a dividend.
Stay on top of RCKT
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
